APA (7th ed.) Citation

Moore, L. E., Baris, D. R., Figueroa, J. D., Garcia-Closas, M., Karagas, M. R., Schwenn, M. R., . . . Rothman, N. (2011). GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: Results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis (New York), 32(2), 182-189. https://doi.org/10.1093/carcin/bgq223

Chicago Style (17th ed.) Citation

Moore, L. E., et al. "GSTM1 Null and NAT2 Slow Acetylation Genotypes, Smoking Intensity and Bladder Cancer Risk: Results from the New England Bladder Cancer Study and NAT2 Meta-analysis." Carcinogenesis (New York) 32, no. 2 (2011): 182-189. https://doi.org/10.1093/carcin/bgq223.

MLA (9th ed.) Citation

Moore, L. E., et al. "GSTM1 Null and NAT2 Slow Acetylation Genotypes, Smoking Intensity and Bladder Cancer Risk: Results from the New England Bladder Cancer Study and NAT2 Meta-analysis." Carcinogenesis (New York), vol. 32, no. 2, 2011, pp. 182-189, https://doi.org/10.1093/carcin/bgq223.